April 29, 2015
Raleigh, NC – Xanofi, a nanomaterial company specializing in rapid product development and Izumi, a cutting-edge technology company, created an 18 short-question, 3D bioprinting survey. The survey went out to over a hundred expert researchers in the 3D bioprinting space. According to Miles Wright, Xanofi CEO, the survey was sent out to obtain insights on what researchers would want to see in 3D printers and how they see them helping in their future projects.
“I was quite pleased with the amount of responses, along with the detailed feedback we have received from the researchers. This kind of feedback is needed and will help Xanofi move in the right direction, “ Miles commented. “We just launched our new website and working diligently on our marketing efforts and we are pleased with the results of those efforts so far.”
Over 70 out of the 100+ researchers responded in full to the survey and of those responses, it was found that over 40% of the research done was focused on cartilage, using synthetic hydrogels and collagen. While vascular research was a close second.
“To make the survey more interesting, we incentivized the researchers by offering a new Apple iPad to one lucky winner” says Miles. “The winner, who will be randomly picked from all the respondents, will be announced May 5th. We also want to thank everyone for their participation and feedback!”
For more information about the survey and to receive a copy of the survey results, please contact Xanofi.
Xanofi, a highly innovative advanced materials company, is changing the global landscape on how nanofibers are manufactured with a new platform process that is highly efficient and easy to integrate into production environments. Using a patented technique called XanoShear™, the scalable Xanofi process can produce short, staple nanofibers at high yields. The ability to control the length of nanofibers allows this technology to find application in a wide swath of both conventional and unconventional applications.
Established in 1977 as a provider of cutting-edge technology within the booming US textile trade, Izumi International, Inc. now collaborates with industry-leading companies all over the world to design turnkey solutions to a diverse range of automation needs. Izumi incorporates tabletop robots, six-axis robots, high end dispensing systems, and other innovative technologies as needed for specialized automation applications.
In 2013, Izumi entered the biosciences market, offering customized laboratory automation and bioprinting systems for pioneering research at leading research institutions. Izumi has partnered with Xanofi to create the world’s first 3D printed scaffold composed of discrete fibers and plans to further expand its bioscience portfolio around this unique capability. For more information about this company, visit: www.izumiinternational.com.
Director of Strategic Alliances